06:30am EDT|
AbCelleraâs Billionaire CEO Says New Covid Treatment Could Be A âGame Changerâ As Global Cases Rise
Share to Facebook
Jens Kristian Balle/The Forbes Collection
The companyâs new antibody treatment, which is heading to clinical trials, works against variants and may be potent enough to be used in areas without a strong medical infrastructure.
In a news briefing Monday, WHO Director-General Tedros Gheybeyesus said that in the last two weeks, thereâve been more new Covid cases than in the first six months of the pandemic. Meanwhile, less than 10% of the global population has had at least one vaccine dose, and less than 5% is fully vaccinated.
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Baylor to test new drug against coronavirus variants
The monoclonal antibody neutralizes all known variants of concern, early trials show
Baylor Scott & White Health’s Dallas campus, which includes Baylor University Medical Center.(Baylor Scott & White)
A new treatment that shows promise in fighting coronavirus variants is going into clinical trials in North Texas.
The treatment, a monoclonal antibody from Eli Lilly and Vancouver-based AbCellera Biologics, neutralized all known variants of concern in preliminary lab tests, including variants first identified in the United Kingdom, South Africa, Brazil, California and New York, AbCellera announced Tuesday morning.
“It [attaches to] the virus in a way that allows it to stop every variant that we have currently seen globally,” said AbCellera CEO Carl Hansen in an interview. He added that it also appears capable of neutralizing the so-called double mutant strain found in India.
May 02, 2021
Ray and Charles Eames
It began shortly after I received the keys to my new home, upon stepping into the now cleared out resale apartment and seeing that wide expanse of floor space, that’s when I started shopping. I like furniture shopping, but what I love even more is shopping for designer furniture.
At first, it was just a statement piece, a Wishbone chair by Hans Wegner. When it comes to shopping for premium furniture, there are dining chairs and then there is the Wishbone.
This is a chair that was designed in 1949 and yet remains as classic and timeless as the day the final sketches were put into production (it was a Wednesday in fact, a little tidbit I uncovered after a trip to visit the Carl Hansen & Son factory in Aarup, Denmark to sift through the archives.
AbCellera breaks ground on new Vancouver HQ as it plans to hire hundreds
AbCellera, Canada’s most valuable biotech company, has broken ground on a new 380,000-square foot tech hub in Vancouver that is set to serve as the company’s new headquarters.
The hub comes in ahead of the Vancouver company’s plans to add “hundreds” of employees to its current 250-person workforce over the next few years, with a particular focus on software, engineering, and bioscience talent.
The headquarters will include two facilities, which are expected to be completed in 2023 and 2024, and being developed in partnership with real estate developers Dayhu Group and Beedie.
vimarsana © 2020. All Rights Reserved.